Clinical Trial Design and Protocol Development

Statistical Considerations for Single-Arm Studies – Clinical Trial Design and Protocol Development

Posted on digi By digi

Single-Arm studies are a type of clinical study where all participants receive the same investigational treatment. It is often used when it is considered unethical to withhold treatment from a control group, especially in oncology studies. However, statistical considerations for single-arm studies can be challenging and require specific methods to derive reliable results. In this tutorial, we will discuss the key statistical considerations for single-arm studies.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Historical Control Data in Single-Arm Designs – Clinical Trial Design and Protocol Development

Posted on digi By digi

Historical control data is a type of analysis that utilizes previously collected data as a control group in a clinical study. This approach is frequently employed in single-arm designs, where only one group of patients is treated and compared to historical controls. Although this method offers a solution for studies where a randomized control group is not possible, its use requires careful consideration and rigorous methodology to avoid biases and ensure valid results.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Use of Single-Arm Trials in Rare Diseases – Clinical Trial Design and Protocol Development

Posted on digi By digi

The complexities of conducting clinical trials in rare diseases are numerous, including small patient populations, heterogeneity of disease presentation, and a lack of existing treatment options. One approach that has gained traction in this context is the use of single-arm trials. This tutorial aims to provide an in-depth understanding of the use of single-arm trials in rare diseases, highlighting the benefits and challenges.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Regulatory Acceptance of Single-Arm Evidence – Clinical Trial Design and Protocol Development

Posted on digi By digi

Regulatory acceptance of single-arm evidence is a critical aspect of clinical studies. This method of evidence collection involves the usage of only one group of subjects (test arm), which receives the experimental therapy. The results are then compared with an external control group, often composed of historical data or observational studies. This approach is crucial especially when randomized controlled trials (RCTs), the gold standard for clinical trials, are not feasible or ethical.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Design Challenges Without a Comparator Arm – Clinical Trial Design and Protocol Development

Posted on digi By digi

Clinical trials are an essential part of drug development and approval processes. They provide the necessary evidence for the safety and effectiveness of new drugs. One notable challenge in designing clinical trials is when the trial lacks a comparator arm. This article aims to explore these challenges and provide solutions to overcome them.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Limitations of External Controls in Oncology – Clinical Trial Design and Protocol Development

Posted on digi By digi

In the field of oncology, external controls are often used in clinical trials to compare the efficacy and safety of a new treatment with a standard or control treatment. They are considered an important aspect of the experimental design. However, there are certain limitations of external controls that can potentially affect the validity and reliability of the results. This article aims to discuss these limitations in detail.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Endpoints Best Suited for Single-Arm Studies – Clinical Trial Design and Protocol Development

Posted on digi By digi

In the world of clinical research, single-arm studies have gained significant prominence as a reliable study design. Single-arm studies are typically observational studies where all participants receive the same intervention, without a comparison group. This design is often used when it would be unethical or impractical to have a control group, or when historical controls are available for comparison. However, choosing the right endpoints for single-arm studies can be a complex task that requires considerable thought and expertise.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Bias and Interpretation Issues in Single-Arm Trials – Clinical Trial Design and Protocol Development

Posted on digi By digi

Single-arm trials have become increasingly popular in clinical research, primarily when evaluating the efficacy of new treatments in rare diseases or severe conditions where a placebo control could be deemed unethical. In this article, we will delve into some of the inherent bias and interpretation issues that can arise during single-arm trials, and discuss ways to mitigate these issues, keeping in line with EMA regulatory guidelines.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Innovative Uses of Single-Arm Trials in Early Phases – Clinical Trial Design and Protocol Development

Posted on digi By digi

Single-arm trials are increasingly gaining popularity in early phase clinical studies due to their innovative applications. This experimental design, where all participants receive the investigational treatment, offers some advantages over randomized controlled trials in certain circumstances. This article delves into the innovative uses of single-arm trials in early phases and their role in shaping future clinical research.
Click to read the full article.

Clinical Trial Design and Protocol Development, Single-Arm Trials

Defining Open-Label Trial Structures and Use Cases – Clinical Trial Design and Protocol Development

Posted on digi By digi

Open-label trials, also known as unblinded studies, are a type of clinical research study where both the researchers and the participants are aware of the treatment or intervention being administered. This contrasts with double-blind trials, where neither party knows which treatment is being given. Open-label trials are an important part of the drug approval process by FDA and other regulatory bodies like the SFDA. They help provide valuable information about the safety and efficacy of new treatments.
Click to read the full article.

Clinical Trial Design and Protocol Development, Open-Label Studies